Urinary endothelin-1-like immunoreactivity excretion in Wilms tumor survivors
Pediatric Nephrology, 04/24/2012Imperiale A et al.
According to the authors' results, urinary endothelin (ET)–1–like Immunoreactivity (uET–1 L) seems to be a marker of glomerular injury in patients with renal mass loss revealing renal overload condition. The uET–1 L role in renal damage progression and hemodynamic glomerular worsening in nephrectomized patients should be proven by prospective long–term follow–up studies, even for potential ET–1 receptor antagonist therapeutic use.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.